| ²é¿´: 575 | »Ø¸´: 3 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
xcs320721ľ³æÖ®Íõ (ÖªÃû×÷¼Ò)
|
[ÇóÖú]
Ç󣺷ÒëÓ¢ÎÄÕªÒª
|
|
| θ°©ÊÇÏû»¯ÏµÍ³×î³£¼ûµÄ¶ñÐÔÖ×Áö£¬´«Í³µÄÊÖÊõÖÎÁƺͻ¯ÁÆÔ¤ºó½Ï²î¡£°ÐÏòÖÎÁÆÊǽüÄêÀ´Ö×ÁöÖÎÁÆÁìÓòÖеÄÑо¿Èȵ㡣´ËÎļòÒª½éÉÜÁ˼¸ÖÖÒ×Óëθ°©Ï¸°û±íÃæ¸ß±í´ï¿¹ÔÏà½áºÏµÄµ¥¿¹¼°Æä°ÐÏò»úÀí¡¢¿¹Ìå½éµ¼µÄ°ÐÏòÔØÒ©ÏµÍ³£¬·ÖÎö²¢±È½ÏÁË¿¹Ìå°ÐÏòÓë·Ç°ÐÏòÄÉÃ×Á£µÄ×÷Óá£×îºó½éÉÜÁË¿¹Ìå¼°Æä°ÐÏòÒ©ÎïÔÚÁÙ´²Ñо¿ÖеÄÓ¦Ó㬲¢Ìá³öÉÐÐè½â¾öµÄ¼¸µãÎÊÌâ¡£ |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ£¬³õÊԳɼ¨350Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ4È˻ظ´
323·Ö£¨¼ÆËã»úÊÓ¾õºÍ´óÄ£ÐÍÏîÄ¿£©ÄÜÖ±½ÓÉÏÊÖ
ÒѾÓÐ3È˻ظ´
311·Ö 22408 Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
320·ÖÈ˹¤ÖÇÄܵ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸Ö£´ó0705Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0703»¯Ñ§
ÒѾÓÐ10È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
306·Ö²ÄÁÏÓ뻯¹¤Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´

719966429
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 3
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 5247
- Ìû×Ó: 351
- ÔÚÏß: 159.5Сʱ
- ³æºÅ: 2015364
- ×¢²á: 2012-09-20
- ÐÔ±ð: GG
- רҵ: ½ðÊô¹¦ÄܲÄÁÏ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
xcs320721: ½ð±Ò+40, ·ÒëEPI+1, ¡ïÓаïÖú 2012-10-29 15:58:07
phu_grassman: ½ð±Ò+2, thanks for your translation. 2012-10-29 22:01:48
xcs320721: ½ð±Ò+40, ·ÒëEPI+1, ¡ïÓаïÖú 2012-10-29 15:58:07
phu_grassman: ½ð±Ò+2, thanks for your translation. 2012-10-29 22:01:48
| Gastric cancer is the most common digestive system malignant tumor, and the prognosis of traditional surgery and chemotherapy is poor . Targeting therapy is the hot research area of tumors treatment in recent years . Firstly this article briefly introduces several monoclonal antibodies that can be combined with high expression antigens easily, and it's mechanism of target as well as the targeting drug-carried system of antibody mediate.Besides, the roles of antibody target and non-targeted nanoparticles are analyzed and compared. At last, the paper introduces the application of antibody and it's targeted drugs in the clinical research, and puts forward some unsolved problems. |
2Â¥2012-10-29 13:32:08
xcs320721
ľ³æÖ®Íõ (ÖªÃû×÷¼Ò)
- ·ÒëEPI: 1
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ¹ó±ö: 2.261
- ½ð±Ò: 73072.7
- É¢½ð: 1960
- ºì»¨: 125
- ɳ·¢: 4
- Ìû×Ó: 9092
- ÔÚÏß: 1593.1Сʱ
- ³æºÅ: 1366994
- ×¢²á: 2011-08-12
- ÐÔ±ð: GG
- רҵ: ƫ΢·Ö·½³Ì

3Â¥2012-10-29 15:58:53
sanlian_whh
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 476.9
- Ìû×Ó: 332
- ÔÚÏß: 25.1Сʱ
- ³æºÅ: 1915750
- ×¢²á: 2012-07-29
- ÐÔ±ð: GG
- רҵ: ¼ÆËã»úÓ¦Óü¼Êõ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
Carena: ½ð±Ò+1, ¹ÄÀøÐ³æÓ¦Öú£¬»¶Ó³£À´ 2012-11-05 13:04:01
xcs320721: ½ð±Ò+10, ¡ï¡ï¡ïºÜÓаïÖú 2012-11-09 09:52:35
Carena: ½ð±Ò+1, ¹ÄÀøÐ³æÓ¦Öú£¬»¶Ó³£À´ 2012-11-05 13:04:01
xcs320721: ½ð±Ò+10, ¡ï¡ï¡ïºÜÓаïÖú 2012-11-09 09:52:35
| Gastric cancer is the most common digestive system malignant tumor, the traditional surgery and chemotherapy with poor prognosis. Targeting therapy is the treatment of tumors in recent years in the field of research hot spot. This article briefly introduces several easy and gastric cancer cell surface antigen high expression of the combination of single resistance and targeted mechanism, antibody mediated targeted drug delivery system load, this paper analyzed and compared the antibody targeting and not targeted nanoparticles role. At last, the paper introduced the antibody and targeted drugs in the clinical application of research, and puts forward some problems to be solved. |
4Â¥2012-11-01 16:30:16














»Ø¸´´ËÂ¥